Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 3
2005 2
2006 3
2007 3
2008 1
2009 3
2010 4
2011 3
2012 4
2013 3
2014 2
2015 4
2016 3
2018 1
2019 2
2020 3
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Retinoic acid receptors at 35 years.
Petkovich M, Chambon P. Petkovich M, et al. J Mol Endocrinol. 2022 Oct 11;69(4):T13-T24. doi: 10.1530/JME-22-0097. Print 2022 Nov 1. J Mol Endocrinol. 2022. PMID: 36149754 Review.
CYP24A1 and kidney disease.
Petkovich M, Jones G. Petkovich M, et al. Curr Opin Nephrol Hypertens. 2011 Jul;20(4):337-44. doi: 10.1097/MNH.0b013e3283477a7b. Curr Opin Nephrol Hypertens. 2011. PMID: 21610497 Review.
Overcoming microenvironment-mediated protection from ATRA using CYP26-resistant retinoids.
Hernandez D, Palau L, Norsworthy K, Anders NM, Alonso S, Su M, Petkovich M, Chandraratna R, Rudek MA, Smith BD, Jones RJ, Ghiaur G. Hernandez D, et al. Among authors: petkovich m. Leukemia. 2020 Nov;34(11):3077-3081. doi: 10.1038/s41375-020-0790-4. Epub 2020 Mar 9. Leukemia. 2020. PMID: 32152463 Free PMC article. No abstract available.
The metabolism of 1,25(OH)2D3 in clinical and experimental kidney disease.
Turner ME, Rowsell TS, White CA, Kaufmann M, Norman PA, Neville K, Petkovich M, Jones G, Adams MA, Holden RM. Turner ME, et al. Among authors: petkovich m. Sci Rep. 2022 Jun 28;12(1):10925. doi: 10.1038/s41598-022-15033-9. Sci Rep. 2022. PMID: 35764669 Free PMC article.
A nanotherapeutic strategy to target drug-tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer.
Shaurova T, Yan L, Su Y, Rich LJ, Vincent-Chong VK, Calkins H, Pokharel S, Petkovich M, Seshadri M, Wu Y, Hershberger PA. Shaurova T, et al. Among authors: petkovich m. Cancer Commun (Lond). 2023 Apr;43(4):503-507. doi: 10.1002/cac2.12401. Epub 2023 Jan 24. Cancer Commun (Lond). 2023. PMID: 36691995 Free PMC article. No abstract available.
49 results